Clinical Trials Directory

Trials / Sponsors / BPGbio

BPGbio

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
Glioblastoma, Glioblastoma Multiforme
Phase 22022-08-22
CompletedA Safety Study of Orally Administered BPM31510 in Healthy Subjects
Healthy
Phase 12017-01-01
CompletedBPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients
Pancreatic Cancer
Phase 22016-07-06
CompletedA Safety Study of Orally Administered BPM31510 in Healthy Subjects
Healthy
Phase 12015-11-01
CompletedBP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Metastatic Cancer, Cancer, Solid Tumor
Phase 12013-10-01
CompletedCompound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of
Chemotherapy-Induced Alopecia
Phase 12012-09-17
CompletedSafety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors
Solid Tumors
Phase 12011-01-01
CompletedAn Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCI
Squamous Cell Carcinoma
Phase 1 / Phase 22008-06-01
CompletedDose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell
Superficial Basal Cell Carcinoma
Phase 1 / Phase 22008-03-01
WithdrawnDose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cut
Squamous Cell Carcinoma
Phase 22008-03-01